Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome
- PMID: 26855665
- PMCID: PMC4744437
- DOI: 10.1186/s12986-016-0070-5
Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome
Abstract
Background: The treatment of Irritable bowel syndrome (IBS) is still challenging. Partially hydrolyzed guar gum (PHGG) is a known prebiotic fiber. To assess the effects of PHGG on clinical symptoms of IBS patients in a prospective randomized double blind placebo-controlled study.
Methods: Suitable IBS patients were recruited into an 18-week-long study (2 weeks of run-in, 12 weeks of treatment and 4 weeks of follow-up). They were blindly randomized to receive 6 gr of PHGG or placebo. Treatment efficacy was evaluated by the Francis Severity IBS score, the IBS quality-of-life scores and scored parameters of weekly journal of symptoms. Deltas of changes between the final and baseline scores were compared between two groups.
Results: Of 121 patients who underwent randomization, 108 patients (49 in the PHGG group and 59 in the placebo group) had all the data needed for intention-to-treat analysis. A 12-week administration of PHGG led to a significant improvement of journal bloating score in the PHGG group versus placebo (-4.1±13.4 versus -1.2±11.9, P=0.03), as well as in bloating+gasses score (-4.3±10.4 versus -1.12±10.5, P = 0.035). The effect lasted for at least 4 weeks after the last PHGG administration. PHGG had no effect on other journal reported IBS symptoms or on Severity and Quality of life scores. There were no significant side effects associated with PHGG ingestion. The rate of dropouts was significantly higher among patients in the placebo group compared with the PHGG group (49.15% versus 22.45%, respectively, P = 0.01).
Conclusions: The results of this study support the administration of 6 g/day PHGG for IBS patients with bloating.
Trial registration: NCT01779765.
Keywords: Fibers; Irritable bowel syndrome (IBS); Partially hydrolyzed guar gum (PHGG); Prebiotics.
Figures
Similar articles
-
Partially hydrolyzed guar gum in pediatric functional abdominal pain.World J Gastroenterol. 2013 Jan 14;19(2):235-40. doi: 10.3748/wjg.v19.i2.235. World J Gastroenterol. 2013. PMID: 23345946 Free PMC article. Clinical Trial.
-
High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG).Dig Dis Sci. 2002 Aug;47(8):1697-704. doi: 10.1023/a:1016419906546. Dig Dis Sci. 2002. PMID: 12184518 Clinical Trial.
-
Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index.Saudi J Gastroenterol. 2015 Mar-Apr;21(2):104-10. doi: 10.4103/1319-3767.153835. Saudi J Gastroenterol. 2015. PMID: 25843197 Free PMC article.
-
Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome.Nutrition. 2006 Mar;22(3):334-42. doi: 10.1016/j.nut.2005.10.003. Epub 2006 Jan 18. Nutrition. 2006. PMID: 16413751 Review.
-
Role of PHGG as a dietary fiber: a review article.Minerva Gastroenterol Dietol. 2013 Dec;59(4):329-40. Minerva Gastroenterol Dietol. 2013. PMID: 24212352 Review.
Cited by
-
Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.Nutrients. 2022 Aug 17;14(16):3382. doi: 10.3390/nu14163382. Nutrients. 2022. PMID: 36014888 Free PMC article. Review.
-
Role of Diet-Microbiome Interaction in Gastrointestinal Disorders and Strategies to Modulate Them with Microbiome-Targeted Therapies.Annu Rev Nutr. 2023 Aug 21;43:355-383. doi: 10.1146/annurev-nutr-061121-094908. Epub 2023 May 28. Annu Rev Nutr. 2023. PMID: 37380178 Free PMC article. Review.
-
Unveiling the Health Benefits of Prebiotics: A Comprehensive Review.Indian J Microbiol. 2024 Jun;64(2):376-388. doi: 10.1007/s12088-024-01235-4. Epub 2024 Mar 18. Indian J Microbiol. 2024. PMID: 39010994 Free PMC article. Review.
-
Effectiveness of Partially Hydrolyzed Guar Gum in Reducing Constipation in Long Term Care Facility Residents: A Randomized Single-Blinded Placebo-Controlled Trial.J Nutr Health Aging. 2022;26(3):247-251. doi: 10.1007/s12603-022-1747-2. J Nutr Health Aging. 2022. PMID: 35297467 Free PMC article. Clinical Trial.
-
The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge.J Clin Med. 2020 Mar 4;9(3):685. doi: 10.3390/jcm9030685. J Clin Med. 2020. PMID: 32143424 Free PMC article. Review.
References
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical